Filtrovat podle Last updated date SelectpopředFrom - To Datum Datum ukončení Tento týden Tento měsíc Minulý týden Minulý měsíc Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Výsledky (3794) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA evaluating data on booster dose of COVID-19 vaccine Comirnaty in adolescents 8 Únor 2022 News Human COVID-19 Vaccines Public consultation on reflection paper on prophylactic use of antimicrobials in animals 8 Únor 2022 News Veterinary Antimicrobial resistance A stronger role for EMA 31 Leden 2022 News Corporate New gene therapy treatment for patients with relapsed or refractory large B-cell lymphoma 28 Leden 2022 News Human Medicines COVID-19: EMA recommends conditional marketing authorisation for Paxlovid 28 Leden 2022 News Human COVID-19 Medicines New EU rules for safe and high-quality medicines for animals become effective 28 Leden 2022 News Veterinary Regulatory and procedural guidance Medicines Regulatory harmonisation of clinical trials in the EU: Clinical Trials Regulation to enter into application and new Clinical Trials Information System to be launched 25 Leden 2022 News Human Clinical trials Increase in manufacturing capacity for Vaxzevria (previously COVID-19 Vaccine AstraZeneca) 24 Leden 2022 News Human COVID-19 Vaccines Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 18-19 January 2022 21 Leden 2022 News Veterinary Maximum residue limit Medicines International regulators’ recommendations on COVID-19 vaccines and the Omicron variant 21 Leden 2022 News Human COVID-19 1 … 46 47 48 49 50 Page 50 of 380 51 52 53 54 … 380
EMA evaluating data on booster dose of COVID-19 vaccine Comirnaty in adolescents 8 Únor 2022 News Human COVID-19 Vaccines
Public consultation on reflection paper on prophylactic use of antimicrobials in animals 8 Únor 2022 News Veterinary Antimicrobial resistance
New gene therapy treatment for patients with relapsed or refractory large B-cell lymphoma 28 Leden 2022 News Human Medicines
COVID-19: EMA recommends conditional marketing authorisation for Paxlovid 28 Leden 2022 News Human COVID-19 Medicines
New EU rules for safe and high-quality medicines for animals become effective 28 Leden 2022 News Veterinary Regulatory and procedural guidance Medicines
Regulatory harmonisation of clinical trials in the EU: Clinical Trials Regulation to enter into application and new Clinical Trials Information System to be launched 25 Leden 2022 News Human Clinical trials
Increase in manufacturing capacity for Vaxzevria (previously COVID-19 Vaccine AstraZeneca) 24 Leden 2022 News Human COVID-19 Vaccines
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 18-19 January 2022 21 Leden 2022 News Veterinary Maximum residue limit Medicines
International regulators’ recommendations on COVID-19 vaccines and the Omicron variant 21 Leden 2022 News Human COVID-19